Applied Biocatalysis Summit 2020 - Virtual Event

Memo

The current industrial revolution signifies the huge value of protein engineering for API and chemical production. Biocatalytic technologyhas the potential to carry out conventional multi-stage processes into efficient one-pot reactions. The Applied Biocatalysis Summit is the only virtual meeting focused on delivering cost-effective and sustainable biocatalytic processes forindustrial application in the pharmaceutical, chemical and agricultural sectors. Join us and leading experts from Merck, Pfizer, Takeda, GSK, BASF, DuPont Biomaterials and more to discuss new biocatalytic enzyme design, enzyme engineering, cascade pathways, biocatalyst manufacturing and scaling up. Learn how to implement biocatalysis into your manufacturing plan tocreate a sustainable cost-effective process for your business. Enable your company to adopt this green method into your business plan by attending the only dedicated virtual conference in a rapidly growing field of biocatalysis. Running digitally November 17-18, 2020. Group discounts and early booking rates are available. Please visit the website for full pricing information. URLs:Tickets: https://go.evvnt.com/617703-2?pid=5569 Brochure: https://go.evvnt.com/617703-3?pid=5569  Date and Time: On Tuesday November 17, 2020 at 8:00 am ends Wednesday November 18, 2020 at 3:15 pm Prices:Conference Only (BioPharma / Chemical / Agriculture Pricing): USD 1119.00,Conference Only (Service Provider Pricing): USD 1419.00,Conference Conference Only (Academic Pricing): USD 819.00 Speakers: Ryan M. Phelan, Senior Scientist, AbbVie, Adrian Ortiz, Principal Scientist, Amgen, Jacob Grose, Investment Manager, BASF Venture Capital, Jake Janey, Research Fellow, Bristol-Myers Squibb, Matt Robinson, Technical Leader for Downstream Processing, Biocatalysis and Oilseed Processing, Corteva Agriscience, David Dodds, Principal, Dodds and Associates, Christian Lenges, Business Development, DuPont BioMaterials, Doug Fuerst, Technology Development Leader, GlaxoSmithKline, Jacob Forstater, Senior Scientist, Merck and Co., Roger Howard, Associate Research Fellow, Pfizer, Matt Stirling, Senior Scientist, Takeda Pharmaceuticals, John Woodley, Professor Technical, University Denmark, Paul Race, Reader in Biological Chemistry, University of Bristol, Alison Narayan, Assistant Professor, University of Michigan, Todd K. Hyster, Professor, University of Princeton, Larry Drumm, President, Biotechnology International Corporation, Niki Patel, Senior Scientist, Merck and Co.